The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Honoraria - Abbvie; Almac Diagnostics; Astellas Medivation; Janssen; Ventana Medical Systems
Consulting or Advisory Role - Abbvie; Almac Diagnostics; Astellas Medivation; Janssen; Ventana Medical Systems
Research Funding - Astellas Medivation (Inst); GenomeDx (Inst)
Travel, Accommodations, Expenses - Compendia Bioscience; Life Technologies; Thermo Fisher Scientific
An observational study profiling biospecimens from 10,000 metastatic prostate cancer (mPCa) patients to screen for molecular alterations.
 
Won Kim
Consulting or Advisory Role - Bayer; Dendreon; Genentech/Roche
 
Kat Kwiatkowski
Employment - Biodesix; Strata Oncology
Stock and Other Ownership Interests - Biodesix; Epizyme; Loxo; Strata Oncology
 
Justin Brown
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
 
Dan R Rhodes
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Patents, Royalties, Other Intellectual Property - University of Michigan
 
Scott A Tomlins
No Relationships to Disclose
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; Dendreon; EMD Serono; Ferring; GenomeDx; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)